Decreased Diabetes-induced Glycemic Impairment in WKY and SHR Involves Enhanced Skeletal Muscle Slc2a4/GLUT4 Expression

Overview

Journal Diabetol Metab Syndr

Publisher Biomed Central

Specialty Endocrinology

Date 2014 Sep 18

PMID 25228927

Citations 4

Authors

Ana Barbara Alves-Wagner

Robinson Sabino-Silva

Raquel S Campello

Rosana C Mori

Ubiratan F Machado

Affiliations

Soon will be listed here.

Abstract

Background: Hypertension has been associated to diabetes, and participates in the development of diabetic complications. The spontaneously hypertensive rat (SHR) is the gold standard model for the study of hypertension, and experimental diabetes has been currently investigated in SHR. Wistar-Kyoto rat is usually taken as control for SHR, however, regarding the glycemic homeostasis, WKY may be similar to SHR, when compared to the standard Wistar rat, importantly affecting the interpretation of data. Slc2a4 gene, which encodes the GLUT4 protein, is expressed in insulin-sensitive tissues, such as muscle cells and adipocytes, and alteration in Slc2a4/GLUT4 expression is inversely related to glycemic levels. We investigated the effect of diabetes on the expression of Slc2a4/GLUT4 and glycemic control in Wistar-Kyoto and SHR.

Findings: Slc2a4 mRNA (Northern-blotting) and GLUT4 protein (Western-blotting) were investigated in skeletal muscles (soleus and extensor digitorum longus) of Wistar, Wistar-Kyoto and SHR, rendered or not diabetic for 1 month. Non-diabetic SHR shows hyperinsulinemia, and unaltered GLUT4 expression. The hyperglycemia was significantly attenuated in diabetic Wistar-Kyoto and SHR, compared to that observed in diabetic Wistar, although all of them presented the same hypoinsulinemic levels. Besides, diabetes significantly reduced Slc2a4/GLUT4 in Wistar, as expected; however, that was not observed in diabetic Wistar-Kyoto and SHR.

Conclusions: Non-diabetic SHR is insulin resistant, despite unaltered GLUT4 expression. Diabetic Wistar-Kyoto and diabetic SHR presented high Slc2a4/GLUT4 expression in skeletal muscle, as compared to diabetic Wistar. This Slc2a4/GLUT4 regulation does not depend on insulin level and possibly protects the WKY and SHR from severe glycemic impairment.

Citing Articles

Endothelial cells as key players in cerebral small vessel disease.

Kremer R, Williams A, Wardlaw J Nat Rev Neurosci. 2025; 26(3):179-188.

PMID: 39743557 DOI: 10.1038/s41583-024-00892-0.

MicroRNAs-Mediated Regulation of Skeletal Muscle GLUT4 Expression and Translocation in Insulin Resistance.

Esteves J, Enguita F, Machado U J Diabetes Res. 2017; 2017:7267910.

PMID: 28428964 PMC: 5385897. DOI: 10.1155/2017/7267910.

Resveratrol improves glycemic control in insulin-treated diabetic rats: participation of the hepatic territory.

Yonamine C, Pinheiro-Machado E, Michalani M, Freitas H, Okamoto M, Correa-Giannella M Nutr Metab (Lond). 2016; 13:44.

PMID: 27366200 PMC: 4928352. DOI: 10.1186/s12986-016-0103-0.

SGLT1 activity in lung alveolar cells of diabetic rats modulates airway surface liquid glucose concentration and bacterial proliferation.

Oliveira T, Candeia-Medeiros N, Cavalcante-Araujo P, Melo I, Favaro-Pipi E, Fatima L Sci Rep. 2016; 6:21752.

PMID: 26902517 PMC: 4763199. DOI: 10.1038/srep21752.

References

Cabassi A, Vinci S, Cantoni A, Quartieri F, Moschini L, Cavazzini S . Sympathetic activation in adipose tissue and skeletal muscle of hypertensive rats. Hypertension. 2002; 39(2 Pt 2):656-61. DOI: 10.1161/hy0202.103471. View

Patinha D, Afonso J, Sousa T, Morato M, Albino-Teixeira A . Activation of adenosine receptors improves renal antioxidant status in diabetic Wistar but not SHR rats. Ups J Med Sci. 2013; 119(1):10-8. PMC: 3916712. DOI: 10.3109/03009734.2013.851748. View

Ferguson R, Carroll H, Harris A, Maher E, Selby P, Banks R . Housekeeping proteins: a preliminary study illustrating some limitations as useful references in protein expression studies. Proteomics. 2005; 5(2):566-71. DOI: 10.1002/pmic.200400941. View

Katayama S, Inaba M, Maruno Y, Morita T, Awata T, Oka Y . Glucose intolerance in spontaneously hypertensive and Wistar-Kyoto rats: enhanced gene expression and synthesis of skeletal muscle glucose transporter 4. Hypertens Res. 1998; 20(4):279-86. DOI: 10.1291/hypres.20.279. View

Sabino-Silva R, Freitas H, Lamers M, Okamoto M, Santos M, Machado U . Na+-glucose cotransporter SGLT1 protein in salivary glands: potential involvement in the diabetes-induced decrease in salivary flow. J Membr Biol. 2009; 228(2):63-9. DOI: 10.1007/s00232-009-9159-3. View

Schaan B, Irigoyen M, Bertoluci M, de Lima N, Passaglia J, Hermes E . Increased urinary TGF-beta1 and cortical renal GLUT1 and GLUT2 levels: additive effects of hypertension and diabetes. Nephron Physiol. 2005; 100(3):p43-50. DOI: 10.1159/000085413. View

Zecchin H, Bezerra R, Carvalheira J, Carvalho-Filho M, Metze K, Franchini K . Insulin signalling pathways in aorta and muscle from two animal models of insulin resistance--the obese middle-aged and the spontaneously hypertensive rats. Diabetologia. 2003; 46(4):479-91. DOI: 10.1007/s00125-003-1073-0. View

Freitas H, Anhe G, Melo K, Okamoto M, Oliveira-Souza M, Bordin S . Na(+) -glucose transporter-2 messenger ribonucleic acid expression in kidney of diabetic rats correlates with glycemic levels: involvement of hepatocyte nuclear factor-1alpha expression and activity. Endocrinology. 2007; 149(2):717-24. DOI: 10.1210/en.2007-1088. View

Reaven G . The metabolic syndrome: is this diagnosis necessary?. Am J Clin Nutr. 2006; 83(6):1237-47. DOI: 10.1093/ajcn/83.6.1237. View

10.

Correa-Giannella M, Machado U . SLC2A4gene: a promising target for pharmacogenomics of insulin resistance. Pharmacogenomics. 2013; 14(8):847-50. DOI: 10.2217/pgs.13.45. View

11.

Baron A, Brechtel G, Wallace P, Edelman S . Rates and tissue sites of non-insulin- and insulin-mediated glucose uptake in humans. Am J Physiol. 1988; 255(6 Pt 1):E769-74. DOI: 10.1152/ajpendo.1988.255.6.E769. View

12.

de Cingolani G, Caldiz C . Insulin resistance and GLUT-4 glucose transporter in adipocytes from hypertensive rats. Metabolism. 2004; 53(3):382-7. DOI: 10.1016/j.metabol.2003.10.017. View

13.

PATERNOSTRO G, Clarke K, Heath J, SEYMOUR A, Radda G . Decreased GLUT-4 mRNA content and insulin-sensitive deoxyglucose uptake show insulin resistance in the hypertensive rat heart. Cardiovasc Res. 1995; 30(2):205-11. View

14.

Seraphim P, Nunes M, Giannocco G, Machado U . Age related obesity-induced shortening of GLUT4 mRNA poly(A) tail length in rat gastrocnemius skeletal muscle. Mol Cell Endocrinol. 2007; 276(1-2):80-7. DOI: 10.1016/j.mce.2007.07.004. View

15.

Sabino-Silva R, Alves-Wagner A, Burgi K, Okamoto M, Alves A, Lima G . SGLT1 protein expression in plasma membrane of acinar cells correlates with the sympathetic outflow to salivary glands in diabetic and hypertensive rats. Am J Physiol Endocrinol Metab. 2010; 299(6):E1028-37. DOI: 10.1152/ajpendo.00395.2010. View

16.

Vestri S, Okamoto M, de Freitas H, Aparecida Dos Santos R, Nunes M, Morimatsu M . Changes in sodium or glucose filtration rate modulate expression of glucose transporters in renal proximal tubular cells of rat. J Membr Biol. 2001; 182(2):105-12. DOI: 10.1007/s00232-001-0036-y. View

17.

Dimitrakoudis D, Ramlal T, Rastogi S, Vranic M, Klip A . Glycaemia regulates the glucose transporter number in the plasma membrane of rat skeletal muscle. Biochem J. 1992; 284 ( Pt 2):341-8. PMC: 1132643. DOI: 10.1042/bj2840341. View

18.

Kurtz T, Morris Jr R . Biological variability in Wistar-Kyoto rats. Implications for research with the spontaneously hypertensive rat. Hypertension. 1987; 10(1):127-31. DOI: 10.1161/01.hyp.10.1.127. View

19.

Okamoto M, Anhe G, Sabino-Silva R, Marques M, Freitas H, Mori R . Intensive insulin treatment induces insulin resistance in diabetic rats by impairing glucose metabolism-related mechanisms in muscle and liver. J Endocrinol. 2011; 211(1):55-64. DOI: 10.1530/JOE-11-0105. View

20.

Aiello E, Villa-Abrille M, Escudero E, Portiansky E, Perez N, Camilion de Hurtado M . Myocardial hypertrophy of normotensive Wistar-Kyoto rats. Am J Physiol Heart Circ Physiol. 2003; 286(4):H1229-35. DOI: 10.1152/ajpheart.00779.2003. View